首页> 外文OA文献 >Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

【2h】

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

机译：放射疗法是用免疫检查点抑制剂，Nivolumab治疗后非小细胞肺癌患者有利预后的独立预后标志物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ou Yamaguchi; Kyoichi Kaira; Kosuke Hashimoto; Atsuto Mouri; Yu Miura; Ayako Shiono; Fuyumi Nishihara; Yoshitake Murayama; Shin‐ei Noda; Shingo Kato; Kunihiko Kobayashi; Hiroshi Kagamu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab [J] . Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, Thoracic cancer. . 2019,第4期

机译：放射疗法是用免疫检查点抑制剂，Nivolumab治疗后非小细胞肺癌患者有利预后的独立预后标志物
2. Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients [J] . Francesco Fiorica, Lorenzo Belluomini, Antonio Stefanelli, American Journal of Clinical Oncology: Cancer Clinical Trials . 2018,第11期

机译：免疫检查点抑制剂Nivolumab和预处理肺癌患者的放射疗法
3. Febrile Neutropenia in a Patient with Non-Small Cell Lung Cancer Treated with the Immune-Checkpoint Inhibitor Nivolumab [J] . Yasushi Hisamatsu, Ryotaro Morinaga, Erina Watanabe, Case Reports & Clinical Practice Review . 2020,第2a3期

机译：免疫检查点抑制剂Nivolumab治疗非小细胞肺癌患者的发热性中性粒细胞减少
4. Prognostic Modeling and Analysis of Tumor Response to Fractionated Radiotherapy for Patients with Squamous Cell Lung Cancer [C] . Hualiang Zhong, Hoda Sharifi, Haisen Li, International work-conference on bioinformatics and biomedical engineering . 2017

机译：鳞癌对部分放疗的肿瘤反应预后建模与分析
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor nivolumab [O] . Ou Yamaguchi, Kyoichi Kaira, Kosuke Hashimoto, 2019

机译：放疗是非小细胞肺癌患者接受免疫检查点抑制剂nivolumab治疗后预后良好的独立预后指标
7. Prognostic Value of the Lung Immune Prognostic Index May Differ in Patients Treated With Immune Checkpoint Inhibitor Monotherapy or Combined With Chemotherapy for Non-small Cell Lung Cancer [O] . Wenxian Wang, Zhangzhou Huang, Zongyang Yu, 2020

机译：肺免疫预后指数的预后价值可能因免疫检查点抑制剂单药治疗或与非小细胞肺癌的化疗结合的患者不同
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Radiotherapy is an independent prognostic marker of favorable prognosis in non‐small cell lung cancer patients after treatment with the immune checkpoint inhibitor, nivolumab

著录项

引文网络

相似文献

相关主题

期刊订阅